She added that she worries people are throwing money away trying lower doses since they likely wont be as effective
The role of research peptides Because retatrutide is not yet approved, researchers who want to study it currently rely on research-grade peptide
April 2026: The newly-consolidated NAION multidistrict litigation has 73 cases in its docket as of April 1, 2026
But during certain life transitionslike chronic stress, postpartum changes, perimenopause, menopause, or long-standing insulin resistancethose signals can become less responsive
We now have therapies that are actually helping people. On supporting science journalism If you're enjoying this article, consider supporting our award-winning journalism by subscribing
In a trial, participants receiving higher doses experienced approximately 20 percent greater weight loss over 48 weeks